A Phase 2a Multicenter, Double-Blind, Placebo-Controlled, Crossover Trial to Investigate the Efficacy, Safety, and Toleration of CP-866,087 (a High-Affinity Mu-Opioid Receptor Antagonist) in Premenopausal Women Diagnosed with Female Sexual Arousal Disorder (FSAD)

✍ Scribed by Shindel, A.W.

• Book ID: 127377431
• Publisher: Elsevier Science
• Year: 2014
• Weight: 49 KB
• Volume: 2014
• Category: Article
• ISSN: 0084-4071
• DOI: 10.1016/j.yuro.2014.01.017